{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:17:36Z","timestamp":1790630256172,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lanzhou Science and Technology Plan Project","award":["2025-2-154"],"award-info":[{"award-number":["2025-2-154"]}]},{"name":"Gansu Provincial Joint Research Foundation General Project","award":["25JRRA1269"],"award-info":[{"award-number":["25JRRA1269"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473266"],"award-info":[{"award-number":["82473266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15084-x","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:42:56Z","timestamp":1762828976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["KLC3 drives gastric cancer progression by stabilizing SLC2A5 to activate MAPK signaling and promote epithelial-mesenchymal transition"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"6","key":"15084_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA cancer J Clin. 2020;70(4):313]. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"10251","key":"15084_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5.","journal-title":"Lancet"},{"key":"15084_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286:18\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002.","journal-title":"Cancer Genet"},{"issue":"4","key":"15084_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/humupd\/dmx010","volume":"23","author":"NJ Camlin","year":"2017","unstructured":"Camlin NJ, McLaughlin EA, Holt JE. Motoring through: the role of kinesin superfamily proteins in female meiosis. Hum Reprod Update. 2017;23(4):409\u201320. https:\/\/doi.org\/10.1093\/humupd\/dmx010.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"15084_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/cas.12138","volume":"104","author":"X Liu","year":"2013","unstructured":"Liu X, Gong H, Huang K. Oncogenic role of Kinesin proteins and targeting Kinesin therapy. Cancer Sci. 2013;104(6):651\u20136. https:\/\/doi.org\/10.1111\/cas.12138.","journal-title":"Cancer Sci"},{"issue":"4","key":"15084_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/cm.970120403","volume":"12","author":"MC Wagner","year":"1989","unstructured":"Wagner MC, Pfister KK, Bloom GS, Brady ST. Copurification of Kinesin polypeptides with microtubule-stimulated Mg-ATPase activity and kinetic analysis of enzymatic properties. Cell Motil Cytoskeleton. 1989;12(4):195\u2013215. https:\/\/doi.org\/10.1002\/cm.970120403.","journal-title":"Cell Motil Cytoskeleton"},{"key":"15084_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2019.06.009","volume":"45","author":"A Moamer","year":"2019","unstructured":"Moamer A, Hachim IY, Binothman N, Wang N, Lebrun JJ, Ali S. A role for kinesin-1 subunits KIF5B\/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis. EBioMedicine. 2019;45:92\u2013107. https:\/\/doi.org\/10.1016\/j.ebiom.2019.06.009.","journal-title":"EBioMedicine"},{"issue":"5","key":"15084_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/bjc.2015.3","volume":"112","author":"M Wang","year":"2015","unstructured":"Wang M, Zhu X, Sha Z, Li N, Li D, Chen L. High expression of Kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients. Br J Cancer. 2015;112(5):874\u201382. https:\/\/doi.org\/10.1038\/bjc.2015.3.","journal-title":"Br J Cancer"},{"issue":"6","key":"15084_CR9","doi-asserted-by":"publisher","first-page":"a004630","DOI":"10.1101\/mcs.a004630","volume":"5","author":"S Dietz","year":"2019","unstructured":"Dietz S, Christopoulos P, Gu L, et al. Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer. Cold Spring Harb Mol Case Stud. 2019;5(6):a004630. https:\/\/doi.org\/10.1101\/mcs.a004630. Published 2019 Dec 13.","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"16","key":"15084_CR10","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/1759-7714.14886","volume":"14","author":"S Qiao","year":"2023","unstructured":"Qiao S, Jiang Y, Li N, Zhu X. The Kinesin light chain-2, a target of mRNA stabilizing protein HuR, inhibits p53 protein phosphorylation to promote radioresistance in NSCLC. Thorac Cancer. 2023;14(16):1440\u201350. https:\/\/doi.org\/10.1111\/1759-7714.14886.","journal-title":"Thorac Cancer"},{"issue":"5","key":"15084_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2592-z","volume":"11","author":"JH Baek","year":"2020","unstructured":"Baek JH, Yun HS, Kim JY, et al. Kinesin light chain 4 as a new target for lung cancer chemoresistance via targeted inhibition of checkpoint kinases in the DNA repair network. Cell Death Dis. 2020;11(5):398. https:\/\/doi.org\/10.1038\/s41419-020-2592-z.","journal-title":"Cell Death Dis"},{"issue":"3","key":"15084_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbrc.2019.06.058","volume":"516","author":"Q Li","year":"2019","unstructured":"Li Q, Zhang Y, Jiang Q. SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy. Biochem Biophys Res Commun. 2019;516(3):619\u201325. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.058.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"15084_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s12885-018-4576-2","volume":"18","author":"R Li","year":"2018","unstructured":"Li R, Xiao C, Liu H, Huang Y, Dilger JP, Lin J. Effects of local anesthetics on breast cancer cell viability and migration. BMC Cancer. 2018;18(1):666. https:\/\/doi.org\/10.1186\/s12885-018-4576-2.","journal-title":"BMC Cancer"},{"key":"15084_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.957655","volume":"13","author":"B Wang","year":"2022","unstructured":"Wang B, Zou D, Wang N, Wang H, Zhang T, Gao L, et al. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer. Front Genet. 2022;13:957655. https:\/\/doi.org\/10.3389\/fgene.2022.957655.","journal-title":"Front Genet"},{"issue":"1","key":"15084_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ceb.2007.11.006","volume":"20","author":"JL Ross","year":"2008","unstructured":"Ross JL, Ali MY, Warshaw DM. Cargo transport: molecular motors navigate a complex cytoskeleton. Curr Opin Cell Biol. 2008;20(1):41\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2007.11.006.","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"15084_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3892\/ijo_00000710","volume":"37","author":"B Monzavi-Karbassi","year":"2010","unstructured":"Monzavi-Karbassi B, Hine RJ, Stanley JS, Ramani VP, Carcel-Trullols J, Whitehead TL, et al. Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. Int J Oncol. 2010;37(3):615\u201322. https:\/\/doi.org\/10.3892\/ijo_00000710.","journal-title":"Int J Oncol"},{"issue":"15","key":"15084_CR17","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-09-4615","volume":"70","author":"H Liu","year":"2010","unstructured":"Liu H, Huang D, McArthur DL, Boros LG, Nissen N, Heaney AP. Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res. 2010;70(15):6368\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4615.","journal-title":"Cancer Res"},{"issue":"1","key":"15084_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.cr.7290257","volume":"15","author":"T Zarubin","year":"2005","unstructured":"Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005;15(1):11\u20138. https:\/\/doi.org\/10.1038\/sj.cr.7290257.","journal-title":"Cell Res"},{"issue":"17","key":"15084_CR19","doi-asserted-by":"publisher","first-page":"e37046","DOI":"10.1016\/j.heliyon.2024.e37046","volume":"10","author":"L Ou","year":"2024","unstructured":"Ou L, Liu H, Peng C, Zou Y, Jia J, Li H, et al. Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon. 2024;10(17):e37046. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37046.","journal-title":"Heliyon"},{"key":"15084_CR20","doi-asserted-by":"publisher","first-page":"1416794","DOI":"10.3389\/fmicb.2024.1416794","volume":"15","author":"L Ou","year":"2024","unstructured":"Ou L, Hao Y, Liu H, Zhu Z, Li Q, Chen Q, et al. Chebulinic acid isolated from aqueous extracts of terminalia chebula Retz inhibits Helicobacter pylori infection by potential binding to Cag A protein and regulating adhesion. Front Microbiol. 2024;15:1416794. https:\/\/doi.org\/10.3389\/fmicb.2024.1416794.","journal-title":"Front Microbiol"},{"key":"15084_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117428","volume":"320","author":"L Ou","year":"2024","unstructured":"Ou L, Liu HR, Shi XY, Peng C, Zou YJ, Jia JW, et al. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. J Ethnopharmacol. 2024;320:117428. https:\/\/doi.org\/10.1016\/j.jep.2023.117428.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"15084_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167844","volume":"1871","author":"H Liu","year":"2025","unstructured":"Liu H, Hamaia SW, Dobson L, Weng J, Hern\u00e1ndez FL, Beaudoin CA, et al. The voltage-gated sodium channel \u03b23 subunit modulates C6 glioma cell motility independently of channel activity. Biochim Biophys Acta Mol Basis Dis. 2025;1871(6):167844. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167844.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"15084_CR23","doi-asserted-by":"publisher","unstructured":"Liu H. Nav channels in cancers: Non-classical roles. Glob J Cancer Ther 6(1): 028\u201332. https:\/\/doi.org\/10.17352\/2581-5407.000032. IF: NA NA NA.","DOI":"10.17352\/2581-5407.000032"},{"key":"15084_CR24","doi-asserted-by":"publisher","first-page":"107558","DOI":"10.1016\/j.pharmthera.2020.107558","volume":"212","author":"H Liu","year":"2020","unstructured":"Liu H, Dilger JP, Lin J. Effects of local anesthetics on cancer cells. Pharmacol Ther. 2020;212:107558. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107558. Epub 2020 Apr 25.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"15084_CR25","doi-asserted-by":"publisher","first-page":"030","DOI":"10.46766\/thegms.pharmaco.20072104","volume":"1","author":"H Liu","year":"2020","unstructured":"Liu H. A clinical mini-review: clinical use of local anesthetics in cancer surgeries. G Med Sci. 2020;1(3):030\u20134. https:\/\/doi.org\/10.46766\/thegms.pharmaco.20072104.","journal-title":"G Med Sci"},{"issue":"F3","key":"15084_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.34257\/GJMRFVOL20IS3PG35","volume":"20","author":"Hengrui Liu","year":"2020","unstructured":"Hengrui Liu. A prospective for the potential effect of local anesthetics on Stem-Like cells in colon cancer. Global J Med Res. 2020;20(F3):35\u20138. https:\/\/doi.org\/10.34257\/GJMRFVOL20IS3PG35.","journal-title":"Global J Med Res"},{"issue":"2","key":"15084_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP. Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37(2):289\u201392. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.02.12.","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"15084_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.19852\/j.cnki.jtcm.2023.02.001","volume":"43","author":"L Hengrui","year":"2023","unstructured":"Hengrui L. An example of toxic medicine used in traditional Chinese medicine for cancer treatment. J Tradit Chin Med. 2023;43(2):209\u201310. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.2023.02.001.","journal-title":"J Tradit Chin Med"},{"key":"15084_CR29","doi-asserted-by":"publisher","unstructured":"Hengrui L. An example of toxic medicine used in traditional Chinese medicine for cancer treatment. J Tradit Chin Med 2023Apr;43(2):209\u201310. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.2023.02.001.","DOI":"10.19852\/j.cnki.jtcm.2023.02.001."},{"issue":"9","key":"15084_CR30","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/cells11091433","volume":"11","author":"ES Fridman","year":"2022","unstructured":"Fridman ES, Ginini L, Gil Z. The role of extracellular vesicles in metabolic reprogramming of the tumor microenvironment. Cells. 2022;11(9):1433. https:\/\/doi.org\/10.3390\/cells11091433.","journal-title":"Cells"},{"key":"15084_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2024.09.001","volume":"288\u2013289","author":"L Jahangiri","year":"2024","unstructured":"Jahangiri L. Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment. Cancer Genet. 2024;288\u2013289:32\u20139. https:\/\/doi.org\/10.1016\/j.cancergen.2024.09.001. Epub 2024 Sep 3.","journal-title":"Cancer Genet"},{"issue":"1","key":"15084_CR32","doi-asserted-by":"publisher","first-page":"19055","DOI":"10.1038\/s41598-023-45774-0","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification. Sci Rep. 2023;13(1):19055. https:\/\/doi.org\/10.1038\/s41598-023-45774-0.","journal-title":"Sci Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15084-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:19:25Z","timestamp":1762874365000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15084-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15084"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15084-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of The Second Hospital of Lanzhou University (the approval number IRB ID: 2023\u00a0A-815, D2023-496).The study is reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1746"}}